sars cov 2 replication transcription complex (Gilead Sciences)
99
Structured Review
Gilead Sciences
sars cov 2 replication transcription complex
Sars Cov 2 Replication Transcription Complex, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 99/100, based on 15646 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sars+cov+2+replication/VEKLURY/emdb_26639-0-19-24
Average 99 stars, based on 15646 article reviews
Sars Cov 2 Replication Transcription Complex, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 99/100, based on 15646 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sars+cov+2+replication/VEKLURY/emdb_26639-0-19-24
Average 99 stars, based on 15646 article reviews
sars cov 2 replication transcription complex - by Bioz Stars,
2026-10
99/100 stars
Images
Related Articles
other:Article Title: Usp25-Erlin1/2 activity limits cholesterol flux to restrict virus infection. Article Snippet: Inhibition:Article Title: Characterization, Directed Evolution, and Targeting of DNA Virus-Encoded RNA Capping Enzymes Using Phenotypic Yeast Platforms. Article Snippet: The constant and the sudden emergence of zoonotic human and animal viruses is a significant threat to human health, the world economy, and the world food supply.. This has necessitated the development of broad-spectrum therapeutic strategies to combat these emerging pathogens.. Mechanisms that are essential for viral replication and propagation have been successfully targeted in the past to develop broad-spectrum therapeutics that can be readily repurposed to combat new zoonotic pathogens. Article Title: Inhibition of SARS-CoV-2 3CL protease by the anti-viral chimeric protein RetroMAD1. Article Snippet: .. The concentrations of RetroMAD1 that demonstrated equally effective inhibition of Virus:Article Title: Inhibition of SARS-CoV-2 3CL protease by the anti-viral chimeric protein RetroMAD1. Article Snippet: .. The concentrations of RetroMAD1 that demonstrated equally effective inhibition of Article Title: Novel Molecular Consortia of Cannabidiol with Nonsteroidal Anti-Inflammatory Drugs Inhibit Emerging Coronaviruses’ Entry Article Snippet: Currently, in the European Union, several drugs have been approved for the treatment of COVID-19: remdesivir (Gilead Sciences, Foster City, CA, USA), PF-07321332, and ritonavir (Pfizer, New York, NY, USA), and monoclonal antibodies, such as sotrovimab (GlaxoSmitkKline, Brentford, UK), casirivimab/imdevimab (Roche, Basel, Switzerland), regdanvimab (Celltrion, Yeonsu-gu, Republic of Korea), and tixagevimab/cilgavimab (AstraZeneca, Cambridge, UK) [ ]. .. However, it should be highlighted that all the above-mentioned therapeutics (i) act directly against Concentration Assay:Article Title: Inhibition of SARS-CoV-2 3CL protease by the anti-viral chimeric protein RetroMAD1. Article Snippet: .. The concentrations of RetroMAD1 that demonstrated equally effective inhibition of Blocking Assay:Article Title: Novel Molecular Consortia of Cannabidiol with Nonsteroidal Anti-Inflammatory Drugs Inhibit Emerging Coronaviruses’ Entry Article Snippet: Currently, in the European Union, several drugs have been approved for the treatment of COVID-19: remdesivir (Gilead Sciences, Foster City, CA, USA), PF-07321332, and ritonavir (Pfizer, New York, NY, USA), and monoclonal antibodies, such as sotrovimab (GlaxoSmitkKline, Brentford, UK), casirivimab/imdevimab (Roche, Basel, Switzerland), regdanvimab (Celltrion, Yeonsu-gu, Republic of Korea), and tixagevimab/cilgavimab (AstraZeneca, Cambridge, UK) [ ]. .. However, it should be highlighted that all the above-mentioned therapeutics (i) act directly against Expressing:Article Title: Stabilization of RNA G-quadruplexes in the SARS-CoV-2 genome inhibits viral infection via translational suppression. Article Snippet: The G-quadruplex (G4) formed in single-stranded DNAs or RNAs plays a key role in diverse biological processes and is considered as a potential antiviral target.. In the genome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), 25 putative G4-forming sequences are predicted; however, the effects of G4-binding ligands on SARS-CoV-2 replication have not been studied in the context of viral infection.. In this study, we investigated whether G4-ligands suppressed SARSCoV-2 replication and whether their antiviral activity involved stabilization of viral RNA G4s and suppression of viral gene expression. Article Title: Modifications of lipid pathways restrict SARS-CoV-2 propagation in human induced pluripotent stem cell-derived 3D airway organoids. Article Snippet: The effect of Remdesivir, the well-established clinical drug for treating COVID-19 [67,68], was also evaluated in another parallel incubation of iPSC-AOs (Supplemental Fig. 4A). .. Immunoblotting and immunofluorescence showed that preincubation of Remdesivir reduced SARS-CoV-2 N protein expression in infected iPSC-AOs (Supplemental Fig. 4B & C), indicating the repression of Western Blot:Article Title: Modifications of lipid pathways restrict SARS-CoV-2 propagation in human induced pluripotent stem cell-derived 3D airway organoids. Article Snippet: The effect of Remdesivir, the well-established clinical drug for treating COVID-19 [67,68], was also evaluated in another parallel incubation of iPSC-AOs (Supplemental Fig. 4A). .. Immunoblotting and immunofluorescence showed that preincubation of Remdesivir reduced SARS-CoV-2 N protein expression in infected iPSC-AOs (Supplemental Fig. 4B & C), indicating the repression of Immunofluorescence:Article Title: Modifications of lipid pathways restrict SARS-CoV-2 propagation in human induced pluripotent stem cell-derived 3D airway organoids. Article Snippet: The effect of Remdesivir, the well-established clinical drug for treating COVID-19 [67,68], was also evaluated in another parallel incubation of iPSC-AOs (Supplemental Fig. 4A). .. Immunoblotting and immunofluorescence showed that preincubation of Remdesivir reduced SARS-CoV-2 N protein expression in infected iPSC-AOs (Supplemental Fig. 4B & C), indicating the repression of Infection:Article Title: Modifications of lipid pathways restrict SARS-CoV-2 propagation in human induced pluripotent stem cell-derived 3D airway organoids. Article Snippet: The effect of Remdesivir, the well-established clinical drug for treating COVID-19 [67,68], was also evaluated in another parallel incubation of iPSC-AOs (Supplemental Fig. 4A). .. Immunoblotting and immunofluorescence showed that preincubation of Remdesivir reduced SARS-CoV-2 N protein expression in infected iPSC-AOs (Supplemental Fig. 4B & C), indicating the repression of |